engleski

Does postnatal use of Lactobacillus reuteri influence outcome of preterm infants less then 32 weeks of gestation?

The aim of this study was to report the neonatal outcomes of preterm infants less than 32 weeks of gestational age (GA) receiving routine administration of the probiotic bacteria Lactobacillus reuteri (L.reuteri) DSM 17938 since the 1st week of life, by comparing them with a retrospective, historical cohort.A total of 146 preterm infants were included in the study with 70 and 76 infants in HC and LrC, respectively. The use of probiotic L. reuteri has a significant effect on reducing the incidence of proven LOS and mortality in preterm infants less than 32 weeks of GA and birth weight less than 1500 g.

Probiotic, Lactobacillus reuteri, Infant, Premature

nije evidentirano